Increased mortality among African American patients with DRESS syndrome compared to White patients.
作者信息
Schneider Justine G, Gallardo Matthew, Fisher Kristopher, Kaffenberger Benjamin H, Korman Abraham M
机构信息
College of Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Department of Dermatology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
出版信息
Int J Dermatol. 2024 Mar;63(3):e80-e81. doi: 10.1111/ijd.16988. Epub 2023 Dec 15.
Abstract
摘要
相似文献
1
Increased mortality among African American patients with DRESS syndrome compared to White patients.
Int J Dermatol. 2024 Mar;63(3):e80-e81. doi: 10.1111/ijd.16988. Epub 2023 Dec 15.
2
Impact of non-genetic factors on severe cutaneous adverse reactions and associated mortality in ESRD patients: Advancing clinical guidance.
Am J Med Sci. 2025 May;369(5):613-619. doi: 10.1016/j.amjms.2025.02.007. Epub 2025 Feb 12.
3
Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement.
Int J Dermatol. 2018 Oct;57(10):1187-1191. doi: 10.1111/ijd.14174. Epub 2018 Aug 11.
4
Shock state: an unrecognized and underestimated presentation of drug reaction with eosinophilia and systemic symptoms.
Shock. 2013 Nov;40(5):387-91. doi: 10.1097/SHK.0000000000000041.
5
Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
Clin Exp Dermatol. 2015 Dec;40(8):851-9. doi: 10.1111/ced.12682. Epub 2015 Aug 14.
6
Clinical, Viral and Genetic Characteristics of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Shanghai, China.
Acta Derm Venereol. 2018 Apr 16;98(4):401-405. doi: 10.2340/00015555-2867.
7
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
J Dermatol. 2019 Mar;46(3):226-233. doi: 10.1111/1346-8138.14776. Epub 2019 Jan 21.
8
Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.
Clin Infect Dis. 2017 May 1;64(9):1198-1203. doi: 10.1093/cid/cix096.
9
Black or African American patients undergo great saphenous vein ablation procedures for advanced venous disease and have the least improvement in their symptoms after these procedures.
J Vasc Surg Venous Lymphat Disord. 2023 Sep;11(5):904-912.e1. doi: 10.1016/j.jvsv.2023.06.002. Epub 2023 Jun 19.
10
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module.
J Allergy Clin Immunol Pract. 2019 Feb;7(2):633-640. doi: 10.1016/j.jaip.2018.08.013. Epub 2018 Aug 31.
引用本文的文献
1
Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease.
Am J Clin Dermatol. 2025 May;26(3):379-393. doi: 10.1007/s40257-025-00924-0. Epub 2025 Jan 31.
2
A Dermatological Dilemma: The Importance of Recognizing Dermatologic Manifestations of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) in Skin of Color Patients.
Cureus. 2024 Jul 8;16(7):e64061. doi: 10.7759/cureus.64061. eCollection 2024 Jul.
本文引用的文献
1
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Clin Dermatol. 2020 Nov-Dec;38(6):702-711. doi: 10.1016/j.clindermatol.2020.06.008. Epub 2020 Jun 27.
2
Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study.
Ann Rheum Dis. 2018 Aug;77(8):1187-1193. doi: 10.1136/annrheumdis-2017-212905. Epub 2018 Apr 13.
3
Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan.
J Am Acad Dermatol. 2013 Mar;68(3):459-65. doi: 10.1016/j.jaad.2012.08.009. Epub 2012 Sep 6.
4
How race becomes biology: embodiment of social inequality.
Am J Phys Anthropol. 2009 May;139(1):47-57. doi: 10.1002/ajpa.20983.
Zotero 插件